Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report)’s share price dropped 6.6% during trading on Tuesday . The company traded as low as $0.3873 and last traded at $0.3873. Approximately 1,498 shares traded hands during mid-day trading, a decline of 93% from the average daily volume of 20,342 shares. The stock had previously closed at $0.4148.
Cell MedX Stock Performance
The business has a 50 day moving average of $0.41 and a 200-day moving average of $0.36.
Cell MedX Company Profile
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Featured Articles
- Five stocks we like better than Cell MedX
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
